HOLX - Hologic - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4364401012
Diagnostic Tests, Medical Imaging Systems, Surgical Instruments
Hologic, Inc. is a leading healthcare company that specializes in developing, manufacturing, and supplying innovative medical products and solutions for women's health, diagnostics, and surgical interventions. The company's diverse portfolio is designed to facilitate early detection and treatment of various health conditions, ultimately improving patient outcomes.
The company operates through four distinct business segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Its Diagnostics segment offers a range of molecular diagnostic assays, including Aptima, which detects infectious microorganisms, and viral load assays for Hepatitis B and C, HIV, and human cytomegalovirus. Additionally, the company provides assays for diagnosing vaginitis and detecting SARS-CoV-2.
In the Breast Health segment, Hologic offers a comprehensive suite of solutions for breast cancer care, including 3D digital mammography systems, image analytics software, and minimally invasive breast biopsy guidance systems. These products enable healthcare professionals to detect and treat breast cancer more effectively, improving patient outcomes.
The GYN Surgical segment focuses on providing innovative solutions for gynecological procedures, such as the MyoSure Hysteroscopic Tissue Removal System for removing fibroids and polyps, and the NovaSure Endometrial Ablation System for treating abnormal uterine bleeding. The company also offers the Fluent Fluid Management System for liquid distention during hysteroscopic procedures and the Acessa ProVu system for treating fibroids.
In the Skeletal Health segment, Hologic provides the Horizon DXA, a dual energy X-ray system, and the Fluoroscan Insight FD mini C-arm for performing minimally invasive orthopedic surgical procedures. These products enable healthcare professionals to diagnose and treat skeletal health conditions more accurately and effectively.
Hologic sells its products through a combination of direct sales, service forces, independent distributors, and sales representatives, ensuring that its innovative solutions reach healthcare providers and patients worldwide. With a rich history dating back to 1985, Hologic is headquartered in Marlborough, Massachusetts, and continues to drive innovation and improvement in women's health and diagnostics.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
HOLX Stock Overview
Market Cap in USD | 18,863m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 1990-06-21 |
HOLX Stock Ratings
Growth 5y | 55.4 |
Fundamental | 62.8 |
Dividend | 0.00 |
Rel. Performance vs Sector | -0.49 |
Analysts | 3.83/5 |
Fair Price Momentum | 78.85 USD |
Fair Price DCF | 108.96 USD |
HOLX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
HOLX Growth Ratios
Growth 12m | 14.89% |
Growth Correlation 12m | 84% |
Growth Correlation 3m | 36% |
CAGR 5y | 10.29% |
CAGR/Mean DD 5y | 0.88 |
Sharpe Ratio 12m | 0.57 |
Alpha vs SP500 12m | -13.45 |
Beta vs SP500 5y weekly | 0.77 |
ValueRay RSI | 38.46 |
Volatility GJR Garch 1y | 17.48% |
Price / SMA 50 | -1.21% |
Price / SMA 200 | 5.11% |
Current Volume | 1245.6k |
Average Volume 20d | 1422.6k |
External Links for HOLX Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 05, 2024, the stock is trading at USD 80.24 with a total of 1,245,584 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -1.69%, over three months by +8.29% and over the past year by +14.22%.
According to ValueRays Forecast Model, HOLX Hologic will be worth about 86.4 in October 2025. The stock is currently trading at 80.24. This means that the stock has a potential upside of +7.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 88.4 | 10.1 |
Analysts Target Price | 86.6 | 7.95 |
ValueRay Target Price | 86.4 | 7.65 |